As technology scales, it is becoming increasingly difficult for simulation and timing models to accurately predict silicon timing behavior. When a collection of chips fail in timing in a similar way, diagnosis and silicon debug look to find the root-causes for the failure. However, little work has been done to develop a methodology that looks for useful design information in the good-chip data. This paper describes a path-based methodology that correlates measured path delays from the good chips, to the path delays predicted by timing analysis. We explain how to utilize this methodology for evaluating the risk of timing modeling.
Explaining the mismatch between predicted timing behavior from modeling and simulation, and the observed timing behavior measured on silicon chips can be very challenging. Given a list of potential sources, the mismatch can be the aggregate result caused by some of them both individually and collectively, resulting in a very large search space. Furthermore, observed data are always corrupted by some unknown statistical random noises. To overcome both challenges, this paper proposes a statistical diagnosis framework that formulates the diagnosis problem as a regression learning problem. In this diagnosis framework, the objective is to rank a set of features corresponding to the list of potential sources of concern. The rank is based on measured silicon path delay data such that a feature inducing a larger unexpected timing deviation is ranked higher. Experimental results are presented to explain the learning method. Diagnosis effectiveness will be demonstrated through benchmark experiments and on an industrial design.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.